Biography

I am from Investigational Clinical and Biochemical Pharmacology group with Focus on early detection of disease marker post COVID 19 vaccine manifestations, Formulation and Development in field of nanomedicine covering various aspects of communicable and non-communicable diseases. Further primary emphasis is stepped on Research of specific topics such as differential pharmacology and toxicology.

Area of Interest:

Pharmacology and Clinical Pharmacology

100%

Cardiovascular Disease

62%

Immunopharmacology

90%

Traditional Medicine

75%

Research Publications in Numbers

Books
0

Chapters
0

Articles
51

Abstracts
0

Selected Publications

Anwar, F., T.O. Asar, F.A. Al-Abassi, V. Kumar and S. Alhayyani, 2022. Natural sea salt in diet ameliorates better protection compared to table salt in the doxorubicin-induced cardiac remodeling. J. Taibah Univ. Sci., 16: 1213-1224.
CrossRef | Direct Link |
S. Naqvi, T.O. Asar, V. Kumar, F.A. Al-Abbasi and S. Alhayyani et al., 2021. A cross-talk between gut microbiome, salt and hypertension. Biomed. Pharmacother., Vol. 134. 10.1016/j.biopha.2020.111156.
CrossRef | Direct Link |
Kumar, V., M. Rahman, P. Gahtori, F. Al-Abbasi, F. Anwar and H.S. Kim, 2020. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine. Expert Opin. Drug Delivery, 18: 673-694.
CrossRef | Direct Link |
Anwar, F., S. Naqvi, F.A. Al-Abbasi, N. Neelofar, V. Kumar, A. Sahoo and M.A. Kamal, 2020. Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed. Curr. Med. Chem., 28: 2392-2408.
CrossRef | Direct Link |
Anwar, F., F.A. Al-Abbasi, M.S. Nadeem, S. Al-Ghamdi and A. Kuerban, 2020. Biochemical evaluation of Nigella sativa L. seeds on fluconazole toxicity in Wistar rats. J. Taibah Univ. Sci. 14: 734-741.
CrossRef | Direct Link |